Berenberg raised the firm’s price target on Novo Nordisk to DKK 1,150 from DKK 950 and keeps a Hold rating on the shares.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NVO:
- Novo Nordisk Takes Legal Route to Crack Down on Copycat Drugs
- Cantor Fitzgerald biotech/biopharma to hold analyst/industry conference call
- Cantor Fitzgerald biotech/biopharma to hold a luncheon meeting
- Novo Nordisk price target raised to DKK 1,150 from DKK 950 at Berenberg
- Eli Lilly price target raised to $500 from $375 at Berenberg